CASE CCC IN THE NEWS
Breast Cancer Survivor's Foundation to Hold 1st Run/Walk Event; Proceeds to Boost Cleveland Clinic Researcher's Work
The Plain Dealer - Sept 30, 2013
Still, Turchi, of Aurora, was captivated by the details surrounding the research that Dr. Vincent Tuohy, an immunologist with the Cleveland Clinic Lerner Research Institute and Case Comprehensive Cancer Center, had been conducting: a vaccine to prevent breast cancer and to keep it from coming back in women who had been treated for the disease.
Antidepressant May Treat Deadly Form of Lung Cancer, Study Finds
Everyday Health - Sept 27, 2013
A little-used class of antidepressants may be the newest weapon against a particular type of lung cancer, according to a new study published in the journal Cancer Discovery. Researchers from the Lucile Packard Children's Hospital at Stanford University found that the antidepressant imipramine was effective at treating small-cell lung cancer — a rare and difficult to beat form of lung cancer...Nathan Pennell, MD, PhD, an oncologist with the Cleveland Clinic and Case Comprehensive Cancer Center, said the findings are exciting, even with the small number of people affected by the disease...
Genetic Mutation Identified in Castration-resistant Prostate Cancer
Helio/HemOnc Today - Sept 26, 2013
"For patients with advanced prostate cancer, treatment can include testosterone deprivation therapy, which works most of the time, but then the tumors invariably become resistant," Case Comprehensive Cancer Center member, Nima Sharifi, MD, Kendrick family chair for prostate cancer research at Cleveland Clinic, told HemOnc Today.
Hyundai Hope on Wheels Donates $500,000 to Clinic and UH Children's Cancer Research
The Plain Dealer - Sept 24, 2013
Hyundai Hope on Wheels, a national effort by Hyundai Motors America to raise money for childhood cancer research, is donating a total of $500,000 to Cleveland children's hospitals this year. The Cleveland Clinic's Children's Hospital and University Hospitals Rainbow Babies & Children's Hospital are two of 41 grant recipients nationwide receiving a total of $10.25 million in funding...The grant to UH Rainbow will fund the work of Dr. Alex Huang, program director of pediatric hematology and oncology, whose research focuses on finding new treatments and therapies for T-cell leukemia. Since 2002, the hospital has received more than $1 million in funding from Hope on Wheels.
The Clinic Children's Hospital grant will fund the research ofDr. Gregory Plautz, department chair of pediatric hematology and oncology, who is working on ways to help the body's own immune system fight cancer. This is the Clinic's second award from Hope On Wheels. Plautz received a $100,000 grant from the program in 2010. Both Plautz and Huang are members of the Case Comprehensive Cancer Center in Cleveland.
Department Interview with Dr. Mukesh Jain
Department of Medicine eNewsletter - Sept 2013
Mukesh Jain, MD, Scientific Director of Harrington Discovery Institute at University Hospitals Case Medical Center, Chief Research Officer of University Hospitals Harrington Heart & Vascular Institute, Director of Case Cardiovascular Research Institute, and member of the Case Comprehensive Cancer Center at Case Western Reserve University, shares his insight on generating quality ideas that lead to NIH funding, offers perspective on effectively mentoring young investigators and discusses the future goals of the Harrington Discovery Institute.
Database of Potential Student Lab Assistants
The Cancer Center has a database of undergraduate and graduate students who are interested in working in cancer research labs or are doing rotations for the Biomedical Sciences Training Program. If you are interested in hosting a student volunteer, employee, or rotation, please contact Lyn Haselton at firstname.lastname@example.org. We appreciate your support and interest in training the next generation of cancer researchers.
Publication Support Acknowledgement
Please remember to acknowledge the valuable support provided by the Cancer Center and its core facilities in your research papers and publications:
"This research was supported by the Case Comprehensive Cancer Center (P30CA043703)." OR
"This research was supported by the [insert facility name] Core Facility of the Case Comprehensive Cancer Center (P30CA043703)."
MARK YOUR CALENDARS
New Treatment Paradigms for Melanoma: A Case-based Discussion
Registration is open for New Treatment Paradigms for Melanoma: A Case-based Discussion, presented by the Case Comprehensive Cancer Center on Friday, October 18 at the Holiday Inn-Cleveland South. This conference is intended to provide melanoma caregivers a case-driven overview of current melanoma treatment paradigms. Case CCC faculty will discuss multidisciplinary approaches to the management of early and late stage melanoma.
The conference will cover the integration of new diagnostic and treatment technologies in care of the melanoma patient. In addition, the role of new targeted and immune therapies in the melanoma treatment as well as management of associated novel toxicities will be reviewed. A case-based discussion format will provide the opportunity audience interaction with the course faculty. CME credit is available.
Graft-versus-Host Disease (GvHD) National Symposium
Registration today the Graft-versus-Host Disease (GvHD) National Symposium, Friday, November 1 at the Embassy Suites Cleveland. This conference is intended to raise awareness about the signs and symptoms of GvHD, review cutting edge approaches to prevention and treatment, and highlight and promote research to further our understanding of its cause. The symposium will have two tracks: a scientifically rigorous one for physicians and practitioners, and a survivor track that will focus on challenges faced by BMT recipients and their families. CME credit is available.
Conquer Cancer Foundation Advanced Clinical Research Award in Breast Cancer
The Conquer Cancer Foundation is accepting Letters of Intent for the 2014 Advanced Clinical Research Award in Breast Cancer. This award is designed to fund mid-career investigators who are committed to clinical cancer research and who wish to conduct original breast cancer research not currently funded.
LOI Deadline: October 21
Application Deadline: December 2
SU2C-Lustgarten Foundation Pancreatic Cancer Convergence Dream Team Translational Research Grant
The American Association for Cancer Research is now accepting submissions of ideas for the Stand Up To Cancer (SU2C)-Lustgarten Foundation Pancreatic Cancer Convergence Dream Team Translational Research Grant. The grant provides three years of funding for research projects that must include therapeutic interventions for pancreatic cancer and deliver near-term patient benefit through investigation by a multidisciplinary, multi-institutional convergence Dream Team of experts. The project must bring together biology (e.g. genomics, epigenetics, proteomics, and/or other biological fields) and at least one additional field of research such as physics, engineering, or immunology.
Deadline: November 7
SU2C-Farrah Fawcett Foundation Human Papillomavirus (HPV) Translational Research Team Grant
The American Association for Cancer Research, on behalf of Stand Up To Cancer (SU2C) and The Farrah Fawcett Foundation, calls upon members of the cancer community to contribute their ideas to the groundbreaking Stand Up To Cancer (SU2C)-Farrah Fawcett Foundation Human Papillomavirus (HPV) Translational Research Team Grant. Ideas are invited for a multidisciplinary translational cancer research project that addresses critical problems in HPV-related cancers and that can deliver near-term patient benefit through investigation by a Team of two expert investigators. The selected grant will include a translational component, and have the potential for a significant impact for patients with HPV-related cancers.
Deadline: November 6
Alex's Lemonade Stand Foundation Innovation Awards
Alex's Lemonade Stand Foundation is accepting Letters of Intent for Innovation Awards. These grants are designed to provide critical and significant seed funding for experienced investigators with a novel and promising approach to finding causes and cures for childhood cancers.
LOI Deadline: November 11
Application Deadline: March 3, 2014